• Explore /
  • Poster
  • / NCI 8609: Interim fluoro-3’-deoxythymidine (FLT) PET imaging findings from the phase I trial of PARP inhibitor veliparib (V) and carboplatin (C) in advanced breast cancer.

NCI 8609: Interim fluoro-3’-deoxythymidine (FLT) PET imaging findings from the phase I trial of PARP inhibitor veliparib (V) and carboplatin (C) in advanced breast cancer.

Abstract Poster

Authors

null

Bhuvaneswari Ramaswamy

The Breast Program, The Ohio State University Comprehensive Cancer Center and the Stefanie Spielman Comprehensive Breast Center, Columbus, OH

Bhuvaneswari Ramaswamy , Jun Zhang , Nathan Hall , Katharina Schregel , Maryam B. Lustberg , Robert Wesolowski , Ewa Mrozek , Rachel M. Layman , Erin Macrae Olson , Susan Ottman , Andrea Camp , Jeffrey J. Chalmers , Susan Michelle Geyer , Miguel Angel Villalona-Calero , Charles L. Shapiro , Michael R. Grever , Michael V. Knopp

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2013 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Breast Cancer - Triple-Negative/Cytotoxics/Local Therapy

Track

Breast Cancer

Sub Track

Triple-Negative Breast Cancer

Clinical Trial Registration Number

NCT01251874

Citation

J Clin Oncol 31, 2013 (suppl; abstr 1023)

DOI

10.1200/jco.2013.31.15_suppl.1023

Abstract #

1023

Poster Bd #

15

Abstract Disclosures

Similar Posters

First Author: S. Viswanathan

First Author: Katherine M. Bell-McGuinn

First Author: George Somlo

First Author: Michael J. Jelinek